These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7026250)

  • 81. Minoxidil therapy in chronic congestive heart failure: acute plus long-term hemodynamic and clinical study.
    McKay CR; Chatterjee K; Ports TA; Holly AN; Parmley WW
    Am Heart J; 1982 Sep; 104(3):575-80. PubMed ID: 7113898
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Determinants of circulatory response to intravenous hydralazine in congestive heart failure.
    Wilson JR; St John Sutton M; Schwartz JS; Ferraro N; Reichek N
    Am J Cardiol; 1983 Aug; 52(3):299-303. PubMed ID: 6869277
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Beneficial effects of hydralazine in severe mitral regurgitation.
    Greenberg BH; Massie BM; Brundage BH; Botvinick EH; Parmley WW; Chatterjee K
    Circulation; 1978 Aug; 58(2):273-9. PubMed ID: 668075
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure.
    Drexler H; Löllgen H; Just H
    Klin Wochenschr; 1981 Jun; 59(12):647-54. PubMed ID: 7253539
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Acute hemodynamic effects of bunazosin in congestive heart failure--differing responses according to degree of cardiac dysfunction.
    Ogino K; Noguchi N; Osaki S; Kitamura H; Matsumoto T; Kato M; Kinugawa T; Miyakoda H; Kotake H; Mashiba H
    Gen Pharmacol; 1993 Jul; 24(4):899-904. PubMed ID: 7901114
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of oral hydralazine on gas exchange in patients with cor pulmonale.
    Miller MJ; Chappell TR; Cook W; De Olazabal JR; Rubin LJ
    Am J Med; 1983 Dec; 75(6):937-42. PubMed ID: 6650548
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Central hemodynamic effects of dipyridamole in severe heart failure: comparison with hydralazine.
    Packer M; Gorlin R; Meller J; Medina N
    Clin Pharmacol Ther; 1982 Jul; 32(1):54-61. PubMed ID: 7083730
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.
    Massie B; Ports T; Chatterjee K; Parmley W; Ostland J; O'Young J; Haughom F
    Circulation; 1981 Feb; 63(2):269-78. PubMed ID: 6778625
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Hemodynamic effects of diuresis by ethacrynic acid in normal subjects and in patients with congestive heart failure.
    Ramírez A; Abelmann WH
    Arch Intern Med; 1968 Apr; 121(4):320-7. PubMed ID: 5645703
    [No Abstract]   [Full Text] [Related]  

  • 90. Usefulness of hydralazine to withdraw from dobutamine in severe congestive heart failure.
    Binkley PF; Starling RC; Hammer DF; Leier CV
    Am J Cardiol; 1991 Oct; 68(10):1103-6. PubMed ID: 1927930
    [No Abstract]   [Full Text] [Related]  

  • 91. Effect of hydralazine on renal failure in patients with congestive heart failure.
    Pierpont GL; Brown DC; Franciosa JA; Cohn JN
    Circulation; 1980 Feb; 61(2):323-7. PubMed ID: 7351057
    [No Abstract]   [Full Text] [Related]  

  • 92. Short-term hemodynamic effects of hydralazine in infants with complete atrioventricular canal defects.
    Artman M; Parrish MD; Boerth RC; Boucek RJ; Graham TP
    Circulation; 1984 May; 69(5):949-54. PubMed ID: 6705171
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Continuous hydralazine infusion for afterload reduction.
    Swartz MT; Kaiser GC; Willman VL; Codd JE; Tyras DH; Barner HB
    Ann Thorac Surg; 1981 Aug; 32(2):188-92. PubMed ID: 7259359
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Nitrate therapy of heart failure in valvular heart disease. Importance of resting level of peripheral vascular resistance in determining cardiac output response.
    Goldberg S; Mann T; Grossman W
    Am J Med; 1978 Jul; 65(1):161-6. PubMed ID: 685988
    [No Abstract]   [Full Text] [Related]  

  • 95. Central and peripheral hemodynamic effects of angiotensin inhibition in patients with refractory congestive heart failure.
    Faxon DP; Creager MA; Halperin JL; Gavras H; Coffman JD; Ryan TJ
    Circulation; 1980 May; 61(5):925-30. PubMed ID: 6153939
    [No Abstract]   [Full Text] [Related]  

  • 96. The effect of oral hydralazine on the pulmonary hemodynamics of patients with pulmonary foreign body granulomatosis.
    Farber H; Glauser FL
    Chest; 1982 Dec; 82(6):708-12. PubMed ID: 7140398
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Oral vasodilator therapy for chronic heart failure: a plea for caution.
    Packer M; Meller J
    Am J Cardiol; 1978 Oct; 42(4):686-9. PubMed ID: 358821
    [No Abstract]   [Full Text] [Related]  

  • 98. Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.
    Armstrong PW; Armstrong JA; Marks GS
    Circulation; 1980 Jul; 62(1):160-6. PubMed ID: 6769608
    [No Abstract]   [Full Text] [Related]  

  • 99. Central and regional hemodynamic effects and neurohumoral consequences of minoxidil in severe congestive heart failure and comparison to hydralazine and nitroprusside.
    Markham RV; Gilmore A; Pettinger WA; Brater DC; Corbett JR; Firth BG
    Am J Cardiol; 1983 Oct; 52(7):774-81. PubMed ID: 6137946
    [No Abstract]   [Full Text] [Related]  

  • 100. Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension.
    Rich S; D'Alonzo GE; Dantzker DR; Levy PS
    Am J Cardiol; 1985 Jan; 55(1):159-63. PubMed ID: 3966375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.